Related references
Note: Only part of the references are listed.Molecular Classification of Rhabdomyosarcoma-Genotypic and Phenotypic Determinants of Diagnosis A Report from the Children's Oncology Group
Elai Davicioni et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Role of CCN, a vertebrate specific gene family, in development
Ken-ichi Katsube et al.
DEVELOPMENT GROWTH & DIFFERENTIATION (2009)
The insulin-like growth factor system and sarcomas
Bart Rikhof et al.
JOURNAL OF PATHOLOGY (2009)
Alternative splicing of CCN mRNAs .... it has been upon us
Bernard Perbal
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2009)
Mouse mesenchymal stem cells expressing PAX-FKHR form alveolar rhabdomyosarcomas by cooperating with secondary mutations
Yue-Xin Ren et al.
CANCER RESEARCH (2008)
CCN3/nephroblastoma overexpressed matricellular protein regulates integrin expression, adhesion, and dissemination in melanoma
Viviana Vallacchi et al.
CANCER RESEARCH (2008)
The CCN3 gene coding for an extracellular adhesion-related protein is transcriptionally activated by the p53 tumor suppressor
Levin Boehlig et al.
CELL CYCLE (2008)
Identification of PAX3-FKHR-regulated genes differentially expressed between alveolar and embryonal rhabdomyosarcoma:: Focus on MYCN as a biologically relevant target
Gabriela E. Mercado et al.
GENES CHROMOSOMES & CANCER (2008)
Prognostic factors in metastatic rhabdomyosarcomas: Results of a pooled analysis from United States and European cooperative groups
Odile Oberlin et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
PDGFR-A is a therapeutic target in alveolar rhabdomyosarcoma
E. Taniguchi et al.
ONCOGENE (2008)
The CCN family of proteins: structure-function relationships
Kenneth P. Holbourn et al.
TRENDS IN BIOCHEMICAL SCIENCES (2008)
Matricellular CCN proteins
Bernard Perbal
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2008)
CCN3: Doctor Jekyll and Mister Hyde
Bernard Perbal
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2008)
Identification of a new class of PAX3-FKHR target promoters: a role of the Pax3 paired box DNA binding domain
L. Zhang et al.
ONCOGENE (2007)
Role for amplification and expression of Glypican-5 in rhabdomyosarcoma
Daniel Williamson et al.
CANCER RESEARCH (2007)
Expression of connective tissue growth factor (CTGF/CCN2) in a mouse model of rhabdomyosarcomagenesis
Stefania Croci et al.
PATHOLOGY & ONCOLOGY RESEARCH (2007)
Nuclear addressing provides a clue for the transforming activity of amino-truncated CCN3 proteins
Nathalie Planque et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
NOV/CCN3 impairs muscle cell commitment and differentiation
Frederico Calhabeua et al.
EXPERIMENTAL CELL RESEARCH (2006)
In Ewing's sarcoma CCN3(NOV) inhibits proliferation while promoting migration and invasion of the same cell type
S Benini et al.
ONCOGENE (2005)
Cell-type-specific regulation of distinct sets of gene targets by Pax3 and Pax3/FKHR
S Begum et al.
ONCOGENE (2005)
Integrin-dependent functions of the angiogenic inducer NOV (CCN3) - Implication in wound healing
CG Lin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
NOV/CCN3 induces adhesion of muscle skeletal cells and cooperates with FGF2 and IGF-1 to promote proliferation and survival
J Lafont et al.
CELL COMMUNICATION AND ADHESION (2005)
Inhibition of connective tissue growth factor (CTGF/CCN2) expression decreases the survival and myogenic differentiation of human rhabdomyosarcoma cells
S Croci et al.
CANCER RESEARCH (2004)
CCN proteins: multifunctional signalling regulators
B Perbal
LANCET (2004)
Cross-talk between the paired domain and the homeodomain of Pax3 - DNA binding by each domain causes a structural change in the other domain, supporting interdependence for DNA binding
S Apuzzo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice:: cooperativity of Ink4a/ARF and Trp53 loss of function
C Keller et al.
GENES & DEVELOPMENT (2004)
Different pattern of matrix metalloproteinases expression in alveolar versus embryonal rhabdomyosarcoma
F Diomedi-Camassei et al.
JOURNAL OF PEDIATRIC SURGERY (2004)
Identification of a novel integrin α6β1 binding site in the angiogenic inducer CCN1 (CYR61)
SJ Leu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
CCN3 (NOV) is a novel angiogenic regulator of the CCN protein family
CG Lin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Pro-angiogenic activities of CYR61 (CCN1) mediated through integrins αvβ3 and α6β1 in human umbilical vein endothelial cells
SJ Leu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
PAX3/Forkhead homolog in rhabdomyosarcoma oncoprotein activates glucose transporter 4 gene expression in vivo and in vitro
M Armoni et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
The expression of ccn3(nov) gene in musculoskeletal tumors
MC Manara et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Inhibition of glioma cell growth and tumorigenic potential by CCN3 (NOV)
N Gupta et al.
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY (2001)
PAX3-FKHR induces morphological change and enhances cellular proliferation and invasion in rhabdomyosarcoma
J Anderson et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
The COOH-terminal transactivation domain plays a key role in regulating the in vitro and in vivo function of Pax3 homeodomain
Y Cao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
